Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatobiliary Disorders”

3,126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,126 results

Not applicableStudy completedNCT05480007
What this trial is testing

Non-alcoholic Fatty Liver Disease and Its Treatment

Who this might be right for
NAFLD
Shanghai 10th People's Hospital 68
Not applicableNot Yet RecruitingNCT07820800
What this trial is testing

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Who this might be right for
Type 2 DiabetesCoronary Heart DiseaseMyocardial Infarction+4 more
University of Eastern Finland 1,400
Testing effectiveness (Phase 2)Study completedNCT03917407
What this trial is testing

DUR-928 in Patients With Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Craig James McClain 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT05050136
What this trial is testing

Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

Who this might be right for
Primary Biliary CholangitisPBC
Mirum Pharmaceuticals, Inc. 333
Not applicableStudy completedNCT01834300
What this trial is testing

The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non Alcoholic Fatty Liver Disease
University of Liverpool 60
Not applicableUnknownNCT05486767
What this trial is testing

Screening of Liver Fibrosis in Adults Without Known Liver Disease

Who this might be right for
Liver Fibrosis
F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica 1,000
Not applicableNot Yet RecruitingNCT06483711
What this trial is testing

Reducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Stanford University 50
Not applicableStudy completedNCT02383485
What this trial is testing

Nonalcoholic Fatty Liver Disease and Atherosclerotic Risk in Children

Who this might be right for
Overweight and ObesityNon-alcoholic Fatty Liver Disease
Augusta University 175
Testing effectiveness (Phase 2)Study completedNCT04971785
What this trial is testing

Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 457
Not applicableStudy completedNCT05546450
What this trial is testing

Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease Patients

Who this might be right for
Fatty Liver DiseaseObesityLiver Fat
Istanbul Gelisim University 108
Not applicableStudy completedNCT03593343
What this trial is testing

Hepatic Glycogen and Fat Oxidation

Who this might be right for
Fatty Liver, NonalcoholicMeal TimeFasting+1 more
Maastricht University Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT06863376
What this trial is testing

Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Tanta University 46
Testing effectiveness (Phase 2)Study completedNCT04134091
What this trial is testing

The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Lipocine Inc. 56
Not applicableUnknownNCT03074708
What this trial is testing

Application of 3D Visualization and 3D Printing in the Hepatobiliary and Pancreatic Surgery

Who this might be right for
Liver DiseasesPancreatic DiseasesBiliary Tract Diseases
Zhujiang Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02117713
What this trial is testing

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 34
Not applicableUnknownNCT05695118
What this trial is testing

Body Composition and Fatty Liver Disease

Who this might be right for
Fatty Liver
Seoul National University Hospital 150
Testing effectiveness (Phase 2)Ended earlyNCT04378010
What this trial is testing

A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

Who this might be right for
Non-Alcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 98
Not applicableLooking for participantsNCT07280390
What this trial is testing

Microplastics, Cirrhosis and Portal Hypertension

Who this might be right for
CirrhosisMicroplasticsPortal Hypertension Related to Cirrhosis+3 more
Post Graduate Institute of Medical Education and Research, Chandigarh 30
Not applicableUnknownNCT05560997
What this trial is testing

Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseMachine Learning
Yan Bi 1,000
Testing effectiveness (Phase 2)Study completedNCT03863574
What this trial is testing

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Zydus Therapeutics Inc. 16
Next Page